1,200 articles
Heikki Joensuu
Heikki Joensuu (born 1956) is a Finnish oncologist and cancer researcher, professor at the University of Helsinki from 1994 to 2019, known for the FinHer breast cancer trial and adjuvant imatinib trials in GIST.
Heine H. Hansen
Heine H. Hansen (1938–2011) was a Danish medical oncologist in Copenhagen who devoted his career to lung cancer and helped found the IASLC and ESMO.
Heinz‐Josef Lenz
Heinz-Josef Lenz is a German-trained American medical oncologist at the University of Southern California who leads gastrointestinal cancer research, known for pharmacogenomics of colorectal cancer drug response.
Helen E. Heslop
Helen E. Heslop is a New Zealand-trained physician-scientist in pediatric oncology at Baylor College of Medicine who pioneered virus-specific T cell therapy for EBV lymphomas and CAR-T immunotherapy.
Hellmut G. Augustin
Hellmut G. Augustin, born 1959, is a German vascular biologist and professor at Heidelberg University who heads vascular oncology research at the German Cancer Research Center.
Henri Coutard
Henri Coutard (1876–1950) was a French radiation therapist at the Curie Institute in Paris who pioneered fractionated radiotherapy, delivering small daily radiation doses over several weeks.
Henry C. Pitot
Henry C. Pitot (1930–2021) was an American physician-scientist who spent his career at the University of Wisconsin–Madison, known for multistage liver carcinogenesis and the Min mouse model of intestinal cancer.
Henry M. Lemon
Henry M. Lemon (1915–1997) was an American physician-scientist who studied estrogen metabolism and breast cancer risk, and was the first director of the Eppley Institute in Nebraska.
Henry S. Kaplan
Henry S. Kaplan (1918–1984) was an American radiation oncologist and cancer biologist at Stanford who developed the first medical linear accelerator in the Western hemisphere and helped make Hodgkin's disease curable.
Henry T. Lynch
Henry T. Lynch, also known as Henry Lynch, was an American cancer geneticist at Creighton University who established that common cancers can be inherited; Lynch syndrome is named after him.
Herbert F. Oettgen
Herbert F. Oettgen (1923–2023) was a German-born tumor immunologist who spent his career at Memorial Sloan Kettering, founding its Division of Applied Immunology in 1970 and pioneering cancer immunotherapy.
Herbert M. Pinedo
Herbert M. Pinedo, known in Dutch medicine as Bob Pinedo, is a Dutch medical oncologist and professor at Vrije Universiteit Amsterdam who pioneered bench-to-bedside cancer research.
Hermann Brenner
Hermann Brenner is a German physician and cancer epidemiologist at the German Cancer Research Center in Heidelberg, known for colorectal cancer screening research and the period-analysis method.
Himisha Beltran
Himisha Beltran is a medical oncologist and physician scientist, Professor of Medicine at Dana-Farber Cancer Institute and Harvard Medical School, known for research on treatment resistance and neuroendocrine prostate cancer.
Hiroyoshi Nishikawa
Hiroyoshi Nishikawa (西川 博嘉, born 1970) is a Japanese tumor immunologist known for work on regulatory T cells in cancer immunity and the immuno-genomic cancer progression hypothesis.
Holcombe E. Grier
Holcombe E. Grier is an American pediatric oncologist and Professor of Pediatrics, Emeritus, at Harvard Medical School, based at Dana-Farber Cancer Institute, known for Ewing sarcoma trials and end-of-life care.
Hope S. Rugo
Hope S. Rugo is an American medical oncologist specializing in breast cancer, known for the phase 3 CAPItello-291 and ASCENT trials and, since 2025, chief of breast medical oncology at City of Hope.
Hossein Borghaei
Hossein Borghaei is an American medical oncologist who leads thoracic medical oncology at Fox Chase Cancer Center in Philadelphia and led the CheckMate 057 trial of nivolumab in lung cancer.
Housheng Hansen He
Housheng Hansen He is a Senior Scientist at the Princess Margaret Cancer Centre and University of Toronto professor known for prostate cancer epigenetics, transcriptional regulation, and circular RNA research.
Howard A. Burris
Howard A. Burris is an American medical oncologist who built Sarah Cannon Research Institute in Nashville into a community-based cancer drug development program and served as ASCO's 56th president.
Howard A. Fine
Howard A. Fine is an American neuro-oncologist, founding Director of the Brain Tumor Center at NewYork-Presbyterian Weill Cornell, known for glioma stem cell research and the GLICO organoid model.
Howard E. Skipper
Howard Earle Skipper was an American cancer researcher at the Southern Research Institute in Birmingham, Alabama, who developed the quantitative basis of modern cancer chemotherapy.
Howard I. Scher
Howard I. Scher is an American medical oncologist specializing in advanced prostate cancer at Memorial Sloan Kettering, who led the phase 3 enzalutamide trial AFFIRM.
Howard M. Sandler
Howard M. Sandler is an American radiation oncologist specializing in prostate cancer who became Chair of Radiation Medicine at Oregon Health & Science University in 2026.
Hua Yu (cancer researcher)
Hua Yu is a cancer researcher and Wilder Professor at City of Hope in Duarte, California, whose laboratory established the signaling protein STAT3 as a molecular target for cancer immunotherapy.
Hugues de The
Hugues de The (Hugues de Thé), born 1959, is a French physician-scientist at the Collège de France who explained how retinoic acid and arsenic cure acute promyelocytic leukemia.
Hui-Kuan Lin
Hui-Kuan Lin (林慧观) is a Taiwanese cancer biologist known for work on ubiquitination and metabolism in cancer, a professor at Duke University elected an Academician of Academia Sinica in 2022.
Hussein A. Tawbi
Hussein A. Tawbi, also known as Hussein Tawbi, is a physician-scientist at MD Anderson Cancer Center who led pivotal immunotherapy trials for melanoma that has spread to the brain.
Hyman B. Muss
Hyman B. Muss is an American medical oncologist specializing in geriatric oncology and breast cancer, who led the first chemotherapy trial in older patients with early-stage breast cancer.
Ian E. Krop
Ian E. Krop is an American medical oncologist and breast cancer drug-development researcher who joined Yale Cancer Center in 2022 after 16 years at Dana-Farber Cancer Institute.